These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Interaction of cyclosporin with CSE inhibitors]. Martini B Med Monatsschr Pharm; 2006 Oct; 29(10):379. PubMed ID: 17058898 [No Abstract] [Full Text] [Related]
7. Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia. Jacobs U; Klein B; Klehr HU Transplant Proc; 1994 Dec; 26(6):3122. PubMed ID: 7998089 [No Abstract] [Full Text] [Related]
8. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem]. Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339 [No Abstract] [Full Text] [Related]
10. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy. Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117 [TBL] [Abstract][Full Text] [Related]
11. Gingival overgrowth in a renal transplant recipient using cyclosporine A. Gonçalves SC; Díaz-Serrano KV; de Queiroz AM; Palioto DB; Faria G J Dent Child (Chic); 2008; 75(3):313-7. PubMed ID: 19040821 [TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels. Mercanoglu F; Turkmen A; Kocaman O; Pinarbasi B; Dursun M; Selcukbiricik F; Sever MS Transplant Proc; 2004 Jun; 36(5):1357-60. PubMed ID: 15251332 [TBL] [Abstract][Full Text] [Related]
13. The cutaneous effects of post-transplant immunosuppression with cyclosporine in Muir-Torre syndrome. Griffard EA; McCoppin HH; Wieberg J; Feldman M J Am Acad Dermatol; 2011 May; 64(5):e86-7. PubMed ID: 21496695 [No Abstract] [Full Text] [Related]
14. Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report. Ghio L; Ferraresso M; Giani M; Mihatsch M; Edefonti A Transplant Proc; 2004 Jun; 36(5):1332-5. PubMed ID: 15251325 [TBL] [Abstract][Full Text] [Related]
15. [Cyclosporin A, renal transplant and hepatocarcinoma]. Indart A; García Bengoechea M; Arenas JI Gastroenterol Hepatol; 2000 Dec; 23(10):498. PubMed ID: 11149227 [No Abstract] [Full Text] [Related]
16. Cyclosporine in renal transplantation: a Scottish experience. Jardine AG; Geddes CC Transplant Proc; 2004 Mar; 36(2 Suppl):139S-142S. PubMed ID: 15041324 [TBL] [Abstract][Full Text] [Related]
17. Kidney transplant recipients and the incidence of adverse reactions to cyclosporin. Tolou-Ghamari Z; Palizban AA Saudi Med J; 2004 Oct; 25(10):1499-500. PubMed ID: 15494834 [No Abstract] [Full Text] [Related]
18. Cyclosporin A-related Raynaud's phenomenon in a renal transplant recipient. Sharma AK; Sunil S; Rustom R; Bone JM; Hammad A; Bakran A; Sells RA Transpl Int; 2002 Oct; 15(9-10):517-8. PubMed ID: 12389086 [No Abstract] [Full Text] [Related]
19. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Jardine AG Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954 [TBL] [Abstract][Full Text] [Related]
20. Florid hyperplastic folliculitis on the chin in a male renal transplant patient. Chua S; Affleck A; Kulkarni K Clin Exp Dermatol; 2008 Jan; 33(1):98-9. PubMed ID: 18039343 [No Abstract] [Full Text] [Related] [Next] [New Search]